Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

BICO Group

17.75 SEK

+6.35 %

Less than 1K followers

BICO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

+6.35 %
-2.79 %
-15.72 %
-15.72 %
-10.40 %
-41.88 %
-67.24 %
-95.49 %
+30.28 %

BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.

Read more
Market cap
1.25B SEK
Turnover
3.08M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
29.4.
2026

Interim report Q1'26

7.5.
2026

General meeting '26

19.8.
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
Let’s revive this thread again. Bico’s 2024 results are out, and after a couple of years in the wilderness, things actually look quite good. Losses have significantly decreased from 2023, and Q4/2024 has been a profitable quarter. Source: https://bico.com/investors/ If anyone is ...
2/21/2025, 9:55 AM
by Karibu
7
Here are the main points from ABG’s latest report. Target price reduced to SEK 35 (210) and recommendation reduced to HOLD (BUY). Preliminary Q2 figures and credit provision Preliminary Q2 sales were SEK 543m (-9% vs ABGSCe 594m) and EBITDA was SEK -20m (-165% vs ABGSCe SEK 31m)....
7/18/2022, 7:34 AM
by Hasbi
7
This news published in early July hadn’t been posted here yet: Next step in Sartorius partnership finalized: several sub-sales and distribution agreements as well as R&D project agreements have been signed BICO Single Press release BICO enables and automates the life science lab ...
7/19/2023, 10:29 AM
by Warren Noutopöytätarjoilu
6
I took a big risk and bought more when it went below thirty, the July share price drop felt so overdone. A pretty good report and the direction of progress looks very good again. As I’m writing this, a +38% reaction to the report BICO Single Press release BICO enables and automates...
11/9/2022, 8:58 AM
by jepukka666
6
Bico is waking up from its coma in spurts. As of this writing, we are seeing the all-time highest one-day share price surge. So Sartorius is buying a 10% stake in Bico, and these are new shares that dilute ownership. Paradoxically, this share issue caused a growth spurt in the stock...
12/9/2022, 1:17 PM
by Karibu
5
And back to the canvas BICO Group AB (publ) today announces the decision to impair goodwill in Ginolis totaling SEK 625 million, ahead of the year-end report 2022 to be published on 22 February 2023. BICO Single Press release BICO enables and automates the life science lab of the...
2/21/2023, 7:07 PM
by Pohjolan Eka
3
Bico Group Audiocast Q3’25: Inderes BICO, Audiocast, Q3'25 - Inderes Time: 2025-11-04 10:00 Language: en Language: en Sector: Health care - Pharmaceuticals & Biotechnology Activity: Audiocast with teleconference
11/4/2025, 12:16 PM
by Isa Hudd
2
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.